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ABSTRACT 
Background: Obesity is a major risk factor for the development of cardiovascular disease. A growing database of clinical evidence implicates 
intra-abdominal adiposity as a powerful driving force for elevated cardiometabolic risk (1). Addressing intra-abdominal adiposity should play a 
central role in future strategies aimed at improving cardiovascular outcomes in patients with abdominal obesity and its associated 
cardiometabolic risk in Sudan. 
Objectives: It is to find the mutation in R-SPONDIN3gene and its association to both of fat deposition around the abdomen and susceptibility to 
cardiovascular disease in Sudanese patients in Khartoum State. 
Material and methods: Conventional PCR was done to detect R- SPONDIN3 in 300 participants (males and females) classified into three groups. 
The first group will include one hundred participants with abdominal obesity, the second group will include one hundred participants already 
diagnosed with CVD entangled with obesity (positive control group), while the third group will include one hundred healthy lean volunteers 
(negative control group). Data was analyzed using SPSS Version 22 software. P value < 0.05 was considered as statistically significant. 
Results: In this study, the results of Conventional PCR were significantly different in (P <0.001) in Heart group subjects as compared to healthy 
controls and obese group. Comparison between the different studied groups according to gene expression showed significant differences (P 
<0.001) mean value of gene expression in healthy group subjects was 1.0 ± 0.0, Obesity group was 2.44 ± 0.50 and heart group subjects was 4.54 
± 0.87 respectively . 
Conclusion: clinically, detect R- SPONDIN3 mutation in patients with diagnosed with CVD entangled with obesity and amount of the gene 
expressed cleared different between obese and CVD subjects entangled with obesity. 
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INTRODUCTION AND LITERATURE REVIEW 
Abdominal obesity, also known as central obesity, is when 
excessive abdominal fat around the stomach and abdomen 
has built up to the extent that it is likely to have a negative 
impact on health. There is a strong correlation between 
central obesity and cardiovascular disease (CVD).  
CVD is now the most common cause of death.  
The etiology of CVD is multifactorial and influenced by 
several factors in addition to obesity (2). Most individuals that 
develop CVD have multiple CVD risk factors. The clustering 
of risk factors observed in many individuals is generally 
referred to as metabolic syndrome. There are several 
different definitions of the metabolic syndrome, but most are 
based on the abdominal obesity (3) . 
Obesity 
Overweight and obesity are defined as abnormal or excessive 
fat accumulation that presents a risk to health. A crude 
population measure of obesity is the body mass index (BMI), 
a person’s weight (in kilogram) divided by the square of his 
or her height (in meter). Obesity is a complex disease, with 
no simple relationship between fat mass and impaired 
health. Simply focusing on fat mass is often inadequate. Some 
individuals have a high quantity of fat but low metabolic risk, 
while others with relatively little fat are at high risk of 
disease development. This variation is largely dependent on 
two factors, size and location of adipocytes (4). While higher 
cut-offs might be applicable in older people (5) . There are 
pros and cons in adapting BMI cut- offs depending on age 
and ethnicity, and the WHO has thus far recommended the 
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same definitions of overweight and obesity to be used 
globally, in all adults, and independent of age. Central fat, 
located around the abdomen, is associated with a greater 
risk of disease than peripheral fat (6). The most commonly 
used measures are Waist Circumference (WC) and Waist to 
Hip Ratio (WHR). Several organizations have defined cut-
points for abdominal obesity around one or both of these 
measurements, with different cut-points for men and 
women: WC>102 cm or WHR≥0.90 for men; WC>88 cm or 
WHR≥0.85 for women. More advanced measurement 
techniques allow for quantification of abdominal and gynoid 
fat masses. Abdominal fat is considered to be fats located on 
the abdomen, while gynoid fat is located at the lower limbs 
and/or around the hip area (7). However, till yet there is no 
consensus on precise definitions of these fat masses, and 
there are therefore no specific recommendations on cut-off 
points. Women, compared to men, have higher percent body 
fat and deposit it in a different pattern, with relatively more 
adipose tissue in the hips and thighs. This female fat 
distribution, independent of total body fat, confers 
protection against metabolic diseases. 
Visceral and central abdominal fat and waist circumference 
show a strong association with type 2 diabetes. Visceral fat, 
also known as organ fat or intra-abdominal fat, is located 
inside the peritoneal cavity, packed in between internal 
organs and torso, as opposed to subcutaneous fat. An excess 
of visceral fat is known as central obesity, the "pot belly" or 
"beer belly" effect, in which the abdomen protrudes 
excessively. This body type is also known as "apple shaped" 
as opposed to "pear shaped" in which fat is deposited on the 
hips and buttocks (8) . 
Genetic determinants of total adiposity and 
distribution in women and men 
Genome-wide association studies (GWAS) recently have 
identified genetic determinants of common polygenic obesity 
that interact with environmental variables in complex ways, 
but so far explain only a small percentage of the inter-
individual variation in BMI.GWAS and meta-analyses of 
GWAS have also identified novel loci associated with central 
or peripheral fat distribution, some of which are sex-specific. 
Differential mRNA expression is also noted between 
abdominal and gluteal tissue (9). R-Spondin 3 (RSPO3) is also 
called cysteine-rich and single thrombospondin domain 
containing-1 (CRISTIN1), protein with TSP type-1 repeat 
(PWTSR), is a member of the R-spondin protein family. R-
spondins (RSPO) are a recently discovered secretory protein 
family with four members in human and mouse. Although all 
four RSPO proteins activate the canonical Wnt pathway, 
RSPO2 and RSPO3 are more potent than RSPO1, whereas 
RSPO4 is relatively inactive. RSPO-3 is expressed 
ubiquitously and expressed at higher level in placenta, small 
intestine, fetal thymus and lymph node. RSPO3 is the 
activator of the beta-catenin signaling cascade, leading to 
TCF-dependent gene activation. RSPO3 acts both in the 
canonical Wnt/beta-catenin-dependent pathway and in non-
canonical Wnt signaling pathway, probably by acting as an 
inhibitor of ZNRF3, an important regulator of the Wnt 
signaling pathway. RSPO3 also acts as a ligand for frizzled 
FZD8 and LRP6 and may negatively regulate the TGF-beta 
pathway. R-SPONDIN3 play a part in controlling fat 
distribution (10) . 
MATERIALS AND METHODS  
Study Design  
This was a case control study to find the mutation in R-
SPONDIN3 . The study were carried out during the period 
from August 2016 to March 2019. 
 Study area 
The study was conducted in Khartoum State in Ahmed Gasim 
hospital Cardiac Surgery and Renal Transplant Center, 
Alshaab Teaching Hospital and Obesity Centers 
Study Group  
The study was include 300 participants (males and females) 
classified into three groups. The first group was include one 
hundred participants with abdominal obesity(obese ), the 
second group was include one hundred participants already 
diagnosed with CVD entangled with obesity (positive control 
group), while the third group was include one hundred 
healthy lean volunteers (negative control group). 
Inclusion Criteria 
Participants with abdominal obesity (obese), participants 
already diagnosed with CVD entangled with obesity (positive 
control group) and hundred lean volunteers. 
Exclusion Criteria  
Any history of chronic hypertension, kidney disease, liver 
disease, coagulation disorders. Prior informed consent was 
taken from all. A detailed history was taken from all subjects 
that include age, history of hypertension, , renal disease, 
hepatic dysfunction or any other acute or chronic illness. 
Details of drug intake was also noted. Blood pressure 
recording along with a detailed physical examination was 
done.  
Ethical considerations: This case control study was 
approved by the research committee – College of Medical 
Laboratory Sciences –Shendi University. Informed consent 
was obtained from each participant before taking the 
samples. 
A simple random sample were taken, seven milliliters 
venous blood samples were withdrawn from fasting 
participants and was divided into 2 tubes under aseptic 
conditions using sterile evacuated tubes from each subject as 
follows: 
- Three milliliters venous blood was put into serum separator 
gel (SSG) tube for performing lipid profile.  
- Four milliliters venous blood was put into a sterile ethylene 
di-amine tetra-acetic acid (EDTA) tube. 
Quality controls and managements: Blood was collected 
with care and adequate safety precautions to ensure test 
results were reliable. Quality Assurance (QA) and standard 
Operating System was followed for all biological and clinical 
tests to achieve validity and reliability of test results. 
Methods of BMI estimation: 
It calculates a value indicative of the fat content of the body 
by dividing the weight by the square of height. 
 
BMI Categories: 
Categories BMI 
Underweight Less than 18.5 
Normal weight 18.5 – 24.9 
Overweight  25 – 29.9 
Obese 30 or higher 
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Statistical Analysis Statistical Analysis 
Data were fed to the computer and analyzed using IBM SPSS 
software package version 20.0.(Armonk, NY: IB was M 
Corp)Qualitative data were described using number and 
percent. The Kolmogorov-Smirnov test was used to verify 
the normality of distribution Quantitative data were 
described using range (minimum and maximum), mean, 
standard deviation and median. Significance of the obtained 
results was judged at the 5% level. Chi-square test was used 
for categorical variables, to compare between different 
groups. Student t-test.was used for normally distributed 
quantitative variables, to compare between two studied 
groups. F-test (ANOVA) was used for normally distributed 
quantitative variables, to compare between more than two 
groups, and Post Hoc test (Tukey) (LSD) for pairwise 
comparisons. Pearson coefficient to correlate between two 
normally distributed quantitative variables. Mann Whitney 
test was used for abnormally distributed quantitative 
variables, to compare between two studied groups. Kruskal 
Wallis test was used for abnormally distributed quantitative 
variables, to compare between more than two studied 
groups, and Post Hoc (Dunn's multiple comparisons test) for 
pairwise comparisons. 
RESULTS 
Conventional PCR was done to all of the three groups 
(control, obesity and heart group).  In this study, the results 
of Conventional PCR were significantly different in (P 
<0.001) in Heart group subjects as compared to healthy 
controls and obese group (Table 1). 
Comparison between the different studied groups according 
to gene expression showed significant differences (P <0.001) 
mean value of gene expression in healthy group subjects was 
1.0 ± 0.0, Obesity group was 2.44 ± 0.50 and heart group 
subjects was 4.54 ± 0.87 respectively  (Table 2) (Figure 1). 
 Correlation between gene expression and age in heart and 
obesity group showed weak positive correlation with the r 
value of age in heart group was 0.034 and obesity group was 
0.007 respectively (Table 3).   
Correlation between gene expression and BMI in heart and 
obesity group showed weak Negative correlation with the r 
value of age in heart group was -0.259 and obesity group was 
0.078 respectively (Table 3).  
Correlation between gene expression and WHR in heart and 
obesity group showed weak Negative correlation with the r 
value of age in heart group was -0.064 and obesity was - 
0.145 respectively (Table 3).  
Comparison between gene expression and fat phenotype 
among the heart group showed significant association (P 
<0.001) mean value of gene expression among heart group 
subjects was 5.0 ± 1.05   Visceral fat and  4.15 ± 0.36 
Subcutaneous fat respectively and Comparison between 
gene expression and fat phenotype among the obesity group 
showed insignificant association (P = 0.663) mean value of 
gene expression among obesity group subjects was 2.45 ± 
0.51   Visceral fat , 2.53 ± 0.51 Gluteal Fat and  4.15 ± 0.36 
Subcutaneous fat respectively (Table 4 ) Figure (2) . 
Comparison between gene expression and sex among the 
heart group showed insignificant association (P = 0.926) 
mean value of gene expression among heart group subjects 
was 4.53 ± 0.91 male and 4.55 ± 0.81 female respectively and 
respectively and Comparison between gene expression and 
sex among the obesity group showed insignificant 
association (P = 0.154) mean value of gene expression 
among obesity group subjects was 2.52 ± 0.51 male and 2.38 
± 0.49 female respectively (Table 5). 
Comparison between the heart and obesity groups according 
to fat phenotypes showed significant differences (P <0.001) 
number 46 and percent 46 % Visceral fat, number 0 and 
percent 0 %  Gluteal Fat and number 54 and percent 54 %  
Subcutaneous fat respectively among the heart group and 
number 31 and percent 31 %  Visceral fat, number 17 and 
percent 17 %  Gluteal Fat and number 52 and percent 52 %   
Subcutaneous fat respectively among the obesity group 
respectively  (Table 6). 
Comparison between the different studied groups according 
to sex showed significant differences (P = 0.035) number 54 
and percent 54 % male and number 46 and percent 46 % 
female among control group, number 60 and percent 60 % 
male and number 40 and percent 40 % female among heart 
group and number 42 and percent 42 % male and number 
58 and percent 58 % female among obesity group 
respectively (Table 7). 
Comparison between the different studied groups according 
to age showed significant differences (P <0.001) mean value 
of age in healthy group subjects 40.70 ± 4.81, Obesity group 
was 43.73 ± 8.85 and heart group subjects was 50.61 ± 8.65 
respectively. Comparison between the control and heart 
groups according to age showed significant differences 
(P1<0.001). Comparison between the control and obesity 
groups according to age showed significant differences (P2 = 
0.015). Comparison between the heart and obesity groups 
according to age showed significant differences (P3 = 
<0.001*) (Table 7). 
Comparison between the different studied groups according 
to BMI showed significant differences (P <0.001) mean value 
of BMI in healthy group subjects 40.70 ± 4.81, Obesity group 
was 43.73 ± 8.85 and heart group subjects was 50.61 ± 8.65 
respectively . Comparison between the control and heart 
groups according to BMI showed significant differences 
(P1<0.001). Comparison between the control and obesity 
groups according to BMI showed significant differences (P2 = 
0.015). Comparison between the heart and obesity groups 
according to BMI showed insignificant differences 
(P3=0.131) (Table 7). 
Comparison between the different studied groups according 
to WHR showed significant differences (P <0.001) mean 
value of WHR in healthy group subjects 40.70 ± 4.81, Obesity 
group was 43.73 ± 8.85 and heart group subjects was 50.61 ± 
8.65 respectively . Comparison between the control and 
heart groups according to WHR showed significant 
differences (P1<0.001). Comparison between the control and 
obesity groups according to WHR showed significant 
differences (P2 = 0.015). Comparison between the heart and 
obesity groups according to WHR showed insignificant 
differences (P3=0.316) (Table 7). 
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Table (1):  Comparison between the different studied groups according to conventional PCR 
Conventional PCR 
Control group 
(n = 100) 
Heart Group 
(n = 100) 
Obesity group 
(n = 100) 2 P 
No. % No. % No. % 
Negative for mutation 100 100.0 81 81.0 100 100.0 
40.569* <0.001* 
Positive for mutation 0 0.0 19 19.0 0 0.0 
 
Table (2): Comparison between the different studied groups according to gene expression 
Gene expression 
Control group 
(n = 100) 
Heart Group 
(n = 100) 
Obesity group 
(n = 100) 
F P 
    
946.172* <0.001* Mean ± SD. 1.0 ± 0.0 4.54 ± 0.87 2.44 ± 0.50 
    
Sig. bet. Grps p1<0.001*,p2<0.001*,p3<0.001*   
 
 
Figure (1):  Comparison between the different studied groups according to gene expression 
 
Table (3):  Correlation between Gene expression and different parameters in each group 
 
Gene expression 
Heart Group Obesity group 
r p r p 
Age (years) 0.034 0.739 0.007 0.948 
BMI (kg/m2) -0.259 0.009* 0.078 0.441 
WHR -0.064 0.525 -0.145 0.150 
 
Table (4): Relation between Fat phenotypes and gene expression in each group 
Gene expression 
Fat phenotypes Test of 
sig. 
p 
Visceral fat Gluteal Fat Subcutaneous fat 
Heart Group (n= 46) (n= 0) (n= 54)   
    
t=5.229* <0.001* Mean ± SD. 5.0 ± 1.05 - 4.15 ± 0.36 
    
Obesity group (n= 31) (n= 17) (n= 52)   
    
F=0.413 0.663 Mean ± SD. 2.45 ± 0.51 2.53 ± 0.51 2.40 ± 0.50 
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Figure (2): Relation between Fat phenotypes and gene expression in each group 
Table (5):  Relation between sex and gene expression in each group 
Gene expression 
Sex 
t p 
Male Female 
Heart Group (n = 60) (n = 40)   
   
0.093 0.926 
Mean ± SD. 4.53 ± 0.91 4.55 ± 0.81 
Obesity group (n = 42) (n = 58)   
   
1.437 0.154 Mean ± SD. 2.52 ± 0.51 2.38 ± 0.49 
   
  
Table (6):  Comparison between the different studied groups according to fat phenotypes 
Fat phenotypes 
Heart Group 
(n = 100) 
Obesity group 
(n = 100) 2 P 
No. % No. % 
Visceral fat 46 46.0 31 31.0 
19.960* <0.001* Gluteal Fat 0 0.0 17 17.0 
Subcutaneous fat 54 54.0 52 52.0 
 
  Table (7):  Comparison between the different studied groups according to demographics data 
 
Control group 
(n = 100) 
Heart Group 
(n = 100) 
Obesity group 
(n = 100) Test of Sig. p 
 No. % No. % No. % 
Sex         
Male 54 54.0 60 60.0 42 42.0 2= 
6.731* 
0.035* 
Female 46 46.0 40 40.0 58 58.0 
Age (years)      
    F= 
43.884* 
<0.001* 
Mean ± SD. 40.70 ± 4.81 50.61 ± 8.65 43.73 ± 8.85 
Sig. bet. Grps p1<0.001*,p2=0.015*,p3<0.001*   
BMI (kg/m2)      
    
F= 
373.477* 
<0.001* Mean ± SD. 21.06 ± 1.41 41.01 ± 7.17 39.44 ± 6.75 
    
Sig. bet. Grps p1<0.001*, p2<0.001*, p3=0.131   
WHR      
    
F= 
106.401* 
<0.001* Mean ± SD. 0.84 ± 0.06 1.05 ± 0.16 1.07 ± 0.14 
    
Sig. bet. Grps p1<0.001*, p2<0.001*, p3=0.316   
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DISCUSSION 
Body fat distribution is a heritable trait that independently 
predicts type 2 diabetes and cardiovascular risk. Genome-
wide association studies (GWAS) meta-analyses have 
identified sexually dimorphic associations, with greater 
effect in women, between loci within RSPO3 (e.g. rs9491696) 
and BMI-adjusted waist-to-hip ratio (WHR). RSPO3 is a LGR4 
receptor ligand and a Wnt/β-catenin signaling agonist. 
The aim of study was to investigate the possible correlation 
between mutation in R-SPONDIN3 gene, abdominal obesity 
and susceptibility to cardiovascular disease. 
The study was include 300 participants (156 males and 144 
females) classified into three groups. The first group was 
include one hundred participants with abdominal obesity 
(obese), the second group was include one hundred 
participants already diagnosed with CVD entangled with 
obesity (Heart Group as positive control group), while the 
third group was include one hundred healthy lean 
volunteers (negative control group).All the participants their 
age group between 27 to 63 years old . BMI and WHR were 
taken for all subjects too. For detection the mutation in 
RSPO3 gene, Conventional PCR was done for control, obesity 
and heart subjects respectively and followed by Real Time 
PCR for all of them .The same of the three group underwent 
for lipid profile. For measurement of fat distribution In 
clinical practice, waist circumference (WC) and WHR were 
used used to determine regional FD. Computerized 
tomography (CT) and whole body MRI scan were used for 
evaluating the adipose tissue which were considered as gold 
standard for that .To measure the visceral and subcutaneous 
abdominal areas in total abdominal area), a CT or MRI scan 
was  taken at the level of L4–L5 or the umbilicus. The ratio of 
visceral to subcutaneous adipose tissue has been shown to 
be strongly correlated with RSPO3 gene in obese subjects 
and heart subjects respectively Abdominal sagittal diameter 
derived from CT or MRI images has also been used to 
determine abdominal FD . The CT and MRI were applied in 
200 volunteers,   
The conventional PCR was done to all of the three groups 
which showed clear variation in the mean value of 
conventional PCR (P <0.001) in Heart group subjects as 
compared to healthy controls and obese group. 
Of the 200 cases (obesity &heart) 19 (19%) were positive for 
mutation in RSPO3 gene all of them from heart group and the 
rest of heart group 81 (81%) were negative for mutation as 
well as obesity group all 0 (0 % ) positive for mutation 
(Table 4 -3). This result was leads us to do real time PCR to 
quantify the level of gene expressed. Comparison between 
the different studied groups according to gene expression 
showed clear variation in the mean value of gene expression 
with (P <0.001) in healthy group subjects  was 1.0 ± 0.0 
,Obesity group was 2.44 ± 0.50 and heart group subjects was 
4.54 ± 0.87 respectively  (Table 2) (Figure 1). This result was 
agreed with the finding of finding of N.Y. Loh(11) . 
In Correlation between gene expression and age in heart and 
obesity group showed weak positive correlation with the r 
value of age in heart group was 0.034 and obesity group was 
0.007 respectively (Table 3).  This result was agreed with 
finding of  Dorit Schleinitz(12).who was carried   study on 
heart and obesity group respectively. 
Correlation between gene expression and BMI in heart and 
obesity group showed weak Negative correlation with the r 
value of age in heart group was -0.259 and obesity group was 
0.078 respectively (Table 3). This result was agreed with 
finding of Michael M (13) . 
Correlation between gene expression and WHR in heart and 
obesity group showed weak Negative correlation with the r 
value of age in heart group was -0.064 and obesity was - 
0.145 respectively (Table 3). This result was agreed with  
Rajiv  G, (14). 
Comparison between gene expression and fat phenotype 
among the heart group showed significant association (P 
<0.001) mean value of gene expression among heart group 
subjects was 5.0 ± 1.05   Visceral fat and  4.15 ± 0.36 
Subcutaneous fat respectively and Comparison between 
gene expression and fat phenotype among the obesity group 
showed insignificant association (P = 0.663) mean value of 
gene expression among obesity group subjects was 2.45 ± 
0.51   Visceral fat , 2.53 ± 0.51 Gluteal Fat and  4.15 ± 0.36 
Subcutaneous fat respectively (Table 4) Figure (2) . This 
result was agreed with finding of  Kalypso Karastergiou(15) 
.but  study the obesity was diagnosed according to the 
Japanese obesity criteria by using CT & MRI Technologies .  
In the Comparison between among heart group according to 
sex and gene expression showed insignificant differences (P 
= 0.926) mean value of gene expression among heart group 
subject was 4.53 ± 0.91 male and 4.55 ± 0.81 female. 
Comparison between among obesity group according to sex 
and gene expression showed insignificant differences (P = 
0.154) mean value of gene expression among heart group 
subject was 2.52 ± 0.51 male and 2.38 ± 0.49 female (Table 
5) .This result was agreed with finding of Atzmon, G (16). 
In the Comparison between the heart and obesity groups 
according to  fat phenotypes showed significant differences 
(P <0.001) number 46 and percent 46 %  Visceral fat, 
number 0 and percent 0 %  Gluteal Fat and number 54 and 
percent 54 % Subcutaneous fat  respectively among the 
heart group and number 31 and percent 31 %  Visceral fat, 
number 17 and percent 17 %  Gluteal Fat and number 52 
and percent 52 % Subcutaneous fat respectively among the 
obesity group respectively  (Table 6). This result was agreed 
with finding of Ian J. Neeland(17)and Tobin M. Abraham(18). 
In the Comparison between the different studied groups 
according to age showed significant differences (P <0.001) 
mean value of age in healthy group subjects 40.70 ± 4.81, 
Obesity group was 43.73 ± 8.85 and heart group subjects 
was 50.61 ± 8.65 respectively. Comparison between the 
control and heart groups according to age showed significant 
differences (P1<0.001). Comparison between the control and 
obesity groups according to age showed significant 
differences (P2 = 0.015). Comparison between the heart and 
obesity groups according to age showed significant 
differences (P3 = <0.001*) (Table7). This result was agreed 
with finding of Kalypso (15). 
In the Comparison between the different studied groups 
according to BMI showed significant differences (P <0.001) 
mean value of BMI in healthy group subjects 40.70 ± 4.81, 
Obesity group was 43.73 ± 8.85 and heart group subjects 
was 50.61 ± 8.65 respectively. Comparison between the 
control and heart groups according to BMI showed 
significant differences (P1<0.001). Comparison between the 
control and obesity groups according to BMI showed 
significant differences (P2 = 0.015). Comparison between the 
heart and obesity groups according to BMI showed 
insignificant differences (P3=0.131)(Table 7) .  
In the Comparison between the different studied groups 
according to WHR showed significant differences (P <0.001) 
mean value of WHR in healthy group subjects 40.70 ± 4.81, 
Obesity group was 43.73 ± 8.85 and heart group subjects 
was 50.61 ± 8.65 respectively. Comparison between the 
control and heart groups according to WHR showed 
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significant differences (P1<0.001). Comparison between the 
control and obesity groups according to WHR showed 
significant differences (P2 = 0.015). Comparison between the 
heart and obesity groups according to WHR showed 
insignificant differences (P3=0.316) (Table 7) . This result 
was agreed with finding of Adamska M (19) who concluded 
the obese and hearts subjects having higher WHR when 
compared with healthy subjects. 
CONCLUSION 
The amount of the R- SPONDIN3 gene expressed cleared 
different between obese and CVD subjects entangled with 
obesity. 
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